Effect of low-dose tacrolimus with mycophenolate mofetil on renal function following liver transplantation

Figure 1 Incidence of chronic kidney disease. A: Incidence of chronic kidney disease (CKD) in the tacrolimus (TAC) and cyclosporine A (CSA) groups (P < 0.05); B: Incidence of CKD in the four TAC subgroups (P < 0.05). The estimated glomerular filtration rate (eGFR) was calculated by the abbreviated modification of diet in renal disease formula after each patient visit. Once the criterion for CKD (eGFR < 60 mL/min per 1.73 m²) was met, the patient was registered in the CKD group.

Figure 2 Kaplan-Meier analysis of cumulative patient survival in patients with and without chronic kidney disease. The cumulative survival was significantly higher in the non-chronic kidney disease (CKD) group (log-rank test, P < 0.05).